Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

60 Degrees Pharmaceuticals (SXTPW)

60 Degrees Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SXTPW
DateTimeSourceHeadlineSymbolCompany
30/01/202522:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
30/01/202519:20GlobeNewswire Inc.60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
30/01/202513:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
29/01/202513:00GlobeNewswire Inc.60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
28/01/202521:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
28/01/202513:01GlobeNewswire Inc.60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic BabesiosisNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
24/01/202521:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
24/01/202521:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
21/01/202522:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
21/01/202521:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
08/01/202521:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
08/01/202513:02GlobeNewswire Inc.60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) BabesiosisNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
23/12/202413:57GlobeNewswire Inc.Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and PreventionNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
19/12/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
11/12/202413:56GlobeNewswire Inc.60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s HospitalNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
09/12/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
21/11/202423:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
14/11/202419:31GlobeNewswire Inc.60 Degrees Pharmaceuticals Announces Third Quarter 2024 ResultsNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
14/11/202418:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
06/11/202422:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
15/10/202419:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
08/10/202412:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
03/10/202413:02GlobeNewswire Inc.60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. LaunchNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
02/10/202414:56Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
01/10/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
19/09/202420:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
11/09/202420:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
06/09/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
06/09/202412:59GlobeNewswire Inc.60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
04/09/202412:00GlobeNewswire Inc.60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:SXTPW60 Degrees Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SXTPW